- Home
- PAMT vs ACHV Comparison
PAMT vs ACHV Comparison
Compare PAMT & ACHV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAMT | ACHV |
|---|---|---|
| Founded | 1980 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Trucking Freight/Courier Services | Biotechnology: In Vitro & In Vivo Diagnostic Substances |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 225.0M | 231.0M |
| IPO Year | 1985 | N/A |
Fundamental Metrics
Financial Performance| Metric | PAMT | ACHV |
|---|---|---|
| Price | $10.65 | $4.22 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.00 | ★ $15.50 |
| AVG Volume (30 Days) | 23.9K | ★ 831.8K |
| Earning Date | 02-06-2026 | 03-10-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $623,270,000.00 | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $12.19 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $8.90 | $1.84 |
| 52 Week High | $17.29 | $6.03 |
Technical Indicators
Market Signals| Indicator | PAMT | ACHV |
|---|---|---|
| Relative Strength Index (RSI) | 44.08 | 34.20 |
| Support Level | $10.06 | $5.12 |
| Resistance Level | $11.15 | $5.70 |
| Average True Range (ATR) | 0.61 | 0.35 |
| MACD | -0.17 | -0.18 |
| Stochastic Oscillator | 26.12 | 0.55 |
Price Performance
Historical ComparisonAbout PAMT PAMT CORP
PAMT Corp is a holding company that is engaged in providing truckload dry van carriers transporting general commodities throughout the continental United States, as well as the Canadian provinces of Ontario and Quebec. It has one reportable segment being motor carrier.
About ACHV Achieve Life Sciences Inc.
Achieve Life Sciences Inc is a specialty pharmaceutical company committed to advancing cytisinicline as a widely available treatment option to help people battling nicotine addiction. It is an established smoking cessation treatment that has been approved and marketed in Central and Eastern Europe. Achieve's focus is to address the smoking health epidemic through the development and commercialization of cytisinicline. It has one operating segment, dedicated to the development and commercialization of cytisinicline for niceon.